Is this page useful for you? Then, help us to keep the service working. Please have a look to our donations page ... Thanks for your help!!

Citation Profile [Updated: 2023-11-03 08:28:08]
5 Years H Index
4
Impact Factor (IF)
0.25
5 Years IF
0.21
Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators
Raw Data

 

IF AIF CIF IF5 DOC CDO CIT NCI CCU D2Y C2Y D5Y C5Y SC %SC CiY II AII
2005 0 0.6 0 0 1 1 0 0 0 0 0 0 0.36
2006 0 0.59 0 0 1 2 0 0 1 1 0 0 0.34
2008 0 0.59 0 0 1 3 3 0 1 2 0 0 0.29
2009 0 0.58 0 0 2 5 0 0 1 3 0 0 0.33
2010 0.33 0.52 0.11 0.2 4 9 0 1 1 3 1 5 1 0 0 0.3
2011 0 0.61 0 0 3 12 5 1 6 8 0 0 0.37
2012 0 0.68 0 0 3 15 6 1 7 10 0 0 0.36
2014 0 0.67 0.11 0.08 3 18 9 2 4 3 12 1 0 1 0.33 0.34
2015 1 0.66 0.3 0.46 5 23 5 7 11 3 3 13 6 1 14.3 1 0.2 0.36
2016 0 0.65 0.04 0.07 4 27 1 1 12 8 14 1 0 0 0.35
2017 0.11 0.62 0.18 0.13 7 34 5 6 18 9 1 15 2 2 33.3 1 0.14 0.35
2018 0.18 0.62 0.21 0.37 9 43 12 9 27 11 2 19 7 1 11.1 2 0.22 0.35
2019 0.25 0.63 0.2 0.18 3 46 0 8 36 16 4 28 5 2 25 0 0.37
2020 0.25 0.72 0.16 0.14 12 58 15 9 45 12 3 28 4 0 1 0.08 0.78
2021 0.33 0.99 0.11 0.17 12 70 0 8 53 15 5 35 6 1 12.5 0 0.41
2022 0.25 0.78 0.16 0.21 6 76 0 12 65 24 6 43 9 0 0 0.25
IF: Two years Impact Factor: C2Y / D2Y
AIF: Average Impact Factor for all series in RePEc in year y
CIF: Cumulative impact factor
IF5: Five years Impact Factor: C5Y / D5Y
DOC: Number of documents published in year y
CDO: Cumulative number of documents published until year y
CIT: Number of citations to papers published in year y
NCI: Number of citations in year y
CCU: Cumulative number of citations to papers published until year y
D2Y: Number of articles published in y-1 plus y-2
C2Y: Cites in y to articles published in y-1 plus y-2
D5Y: Number of articles published in y-1 until y-5
C5Y: Cites in y to articles published in y-1 until y-5
SC: selft citations in y to articles published in y-1 plus y-2
%SC: Percentage of selft citations in y to articles published in y-1 plus y-2
CiY: Cites in year y to documents published in year y
II: Immediacy Index: CiY / Documents.
AII: Average Immediacy Index for series in RePEc in year y
50 most cited documents in this series
#YearTitleCited
12018The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries. (2018). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002009.

Full description at Econpapers || Download paper

7
22012The Many Faces of Innovation. (2012). Sussex, J ; Mordoh, A ; Mestre-Ferrandiz, J. In: Consulting Reports. RePEc:ohe:conrep:000154.

Full description at Econpapers || Download paper

7
32011The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response. (2011). Towse, Adrian ; Devlin, Nancy ; Garrison, L ; Hawe, E. In: Consulting Reports. RePEc:ohe:conrep:000192.

Full description at Econpapers || Download paper

6
42014The Expanding Value Footprint of Oncology Treatments. (2014). Towse, Adrian ; Shah, Koonal ; Garrison, L ; Mestre-Ferrandiz, J ; Hernandez-Villafuerte, K ; Rejon-Parrilla, J C. In: Consulting Reports. RePEc:ohe:conrep:000050.

Full description at Econpapers || Download paper

5
52008Medical Research: Whats It Worth?. (2008). Europe, Rand ; Of, Office . In: Consulting Reports. RePEc:ohe:conrep:000236.

Full description at Econpapers || Download paper

4
62020International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making. (2020). Zhang, Kyann ; Garau, Martina. In: Consulting Reports. RePEc:ohe:conrep:002271.

Full description at Econpapers || Download paper

4
72014The Trajectory of Dementia in the UK - Making a Difference. (2014). O'Neill, Phill ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Cockcroft, L ; Sussex, J ; Lewis, F. In: Consulting Reports. RePEc:ohe:conrep:000518.

Full description at Econpapers || Download paper

3
82020Indication-Based Pricing (IBP) Consultation Report. (2020). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002261.

Full description at Econpapers || Download paper

3
92020A Bargaining Approach: A Theory on ICER Pricing and Optimal Level of Cost-Effectiveness Threshold. (2020). , Towse ; FERRARO, . In: Consulting Reports. RePEc:ohe:conrep:002284.

Full description at Econpapers || Download paper

3
102017Exploring the Assessment and Appraisal of Regenerative Medicines and Cell Therapy Products: Is the NICE Approach Fit for Purpose?. (2017). Towse, Adrian ; Hampson, Grace ; Marsden, G. In: Consulting Reports. RePEc:ohe:conrep:001802.

Full description at Econpapers || Download paper

3
112020Are Cost-Effectiveness Thresholds fit for Purpose for Real-World Decision Making?. (2020). Zhang, Kyann ; Garau, Martina ; Cubi-Molla, Patricia ; Errea, M. In: Consulting Reports. RePEc:ohe:conrep:002247.

Full description at Econpapers || Download paper

3
122015Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?. (2015). Shah, Koonal ; Devlin, Nancy ; Cole, Amanda ; Barnsley, P ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001576.

Full description at Econpapers || Download paper

3
132015Data Governance Arrangements for Real-World Evidence. (2015). Towse, Adrian ; Cole, Amanda ; Mestre-Ferrandiz, J ; Garrison, L. In: Consulting Reports. RePEc:ohe:conrep:001660.

Full description at Econpapers || Download paper

2
142020Meningococcal Vaccines: An International Comparison of Decision-Making Processes, Frameworks and Methodologies. Are Values Missing?. (2020). Lorgelly, Paula ; Shah, K ; Hernandez-Villafuerte, K ; Herdman, M. In: Consulting Reports. RePEc:ohe:conrep:002249.

Full description at Econpapers || Download paper

2
152018Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. (2018). Towse, Adrian ; Garau, Martina. In: Consulting Reports. RePEc:ohe:conrep:001978.

Full description at Econpapers || Download paper

2
162014Obstructive Sleep Apnoea: Health Economics Report. (2014). Garau, Martina ; Sussex, J ; Rejon-Parrilla, J C. In: Consulting Reports. RePEc:ohe:conrep:001504.

Full description at Econpapers || Download paper

2
172018Barriers to Uptake of Minimal Access Surgery in the United Kingdom. (2018). Sampson, Christopher ; Lorgelly, Paula ; Cole, Amanda ; O'Neill, P. In: Consulting Reports. RePEc:ohe:conrep:001976.

Full description at Econpapers || Download paper

2
182016Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making. (2016). Towse, Adrian ; Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Devlin, Nancy ; Cubi-Molla, Patricia. In: Consulting Reports. RePEc:ohe:conrep:001699.

Full description at Econpapers || Download paper

2
19Public Health and Economic Implications of the United Kingdom Exiting the EU and the Single Market. (2017). Lorgelly, Paula ; Hampson, Grace ; Berdud, Mikel ; Maignen, F. In: Consulting Reports. RePEc:ohe:conrep:001933.

Full description at Econpapers || Download paper

1
202018A Critique of the Paper The Estimated Costs of Production and Potential Prices for the World Health Organization Essential Medicines List. (2018). Shaw, B ; Hernandez-Villafuerte, K ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002015.

Full description at Econpapers || Download paper

1
212021Why we need a new Outcomes-based Value Attribution Framework for Combination Regimens in Oncology. (2021). Lothgren, M ; Towse, A ; Bruce, A ; Steuten, L. In: Consulting Reports. RePEc:ohe:conrep:002320.

Full description at Econpapers || Download paper

1
222017Comparing Access to Orphan Medicinal Products (OMPs) in the United Kingdom and other European countries. (2017). Zamora, Bernarda ; Garau, Martina ; Mestre-Ferrandiz, J ; O'Neill, P ; Maignen, F. In: Consulting Reports. RePEc:ohe:conrep:001818.

Full description at Econpapers || Download paper

1
232015Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK. (2015). Karlsberg, Sarah ; Karlsberg Schaffer, Sarah ; Cole, Amanda ; Chapman, A. In: Consulting Reports. RePEc:ohe:conrep:001595.

Full description at Econpapers || Download paper

1
242010Researching the Relative Efficacy and Relative Effectiveness of Medicines across Europe. (2010). Towse, Adrian ; Puig-Peiro, R ; Mestre-Ferrandiz, J. In: Consulting Reports. RePEc:ohe:conrep:000212.

Full description at Econpapers || Download paper

1
252020Realising the Broader Value of Vaccines in the UK. (2020). Brassel, Simon ; Steuten, L ; O'Neill, P ; Neri, M. In: Consulting Reports. RePEc:ohe:conrep:002282.

Full description at Econpapers || Download paper

1
262017Policy Options for Formulary Development in Middle-income Countries. (2017). Towse, Adrian ; Garau, Martina ; Grewal, S ; Garrison, L ; Hernandez-Villafuerte, K. In: Consulting Reports. RePEc:ohe:conrep:001784.

Full description at Econpapers || Download paper

1
272019Public Preferences for Health Gains and Cures: A Discrete Choice Experiment. (2019). Shah, Koonal ; Mott, David ; Hampson, Grace ; Devlin, Nancy. In: Consulting Reports. RePEc:ohe:conrep:002108.

Full description at Econpapers || Download paper

1
28Legal Barriers to the Better Use of Health Data to Deliver Pharmaceutical Innovation. (2018). Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002096.

Full description at Econpapers || Download paper

1
50 most relevant documents in this series (papers most cited in the last two years)
#YearTitleCited
12020International Cost-Effectiveness Thresholds and Modifiers for HTA Decision Making. (2020). Zhang, Kyann ; Garau, Martina. In: Consulting Reports. RePEc:ohe:conrep:002271.

Full description at Econpapers || Download paper

4
22020A Bargaining Approach: A Theory on ICER Pricing and Optimal Level of Cost-Effectiveness Threshold. (2020). , Towse ; FERRARO, . In: Consulting Reports. RePEc:ohe:conrep:002284.

Full description at Econpapers || Download paper

3
32020Indication-Based Pricing (IBP) Consultation Report. (2020). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002261.

Full description at Econpapers || Download paper

3
42020Are Cost-Effectiveness Thresholds fit for Purpose for Real-World Decision Making?. (2020). Zhang, Kyann ; Garau, Martina ; Cubi-Molla, Patricia ; Errea, M. In: Consulting Reports. RePEc:ohe:conrep:002247.

Full description at Econpapers || Download paper

3
52018Barriers to Uptake of Minimal Access Surgery in the United Kingdom. (2018). Sampson, Christopher ; Lorgelly, Paula ; Cole, Amanda ; O'Neill, P. In: Consulting Reports. RePEc:ohe:conrep:001976.

Full description at Econpapers || Download paper

2
62014Obstructive Sleep Apnoea: Health Economics Report. (2014). Garau, Martina ; Sussex, J ; Rejon-Parrilla, J C. In: Consulting Reports. RePEc:ohe:conrep:001504.

Full description at Econpapers || Download paper

2
72018Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. (2018). Towse, Adrian ; Garau, Martina. In: Consulting Reports. RePEc:ohe:conrep:001978.

Full description at Econpapers || Download paper

2
82018The Debate on Indication-Based Pricing in the U.S. and Five Major European Countries. (2018). Zamora, Bernarda ; Cole, Amanda ; Towse, A. In: Consulting Reports. RePEc:ohe:conrep:002009.

Full description at Econpapers || Download paper

2
Citing documents used to compute impact factor: 6
YearTitle
2022Should Hungary Pay More for a QALY Gain than Higher-Income Western European Countries?. (2022). Brodszky, Valentin ; Erdsi, Dalma ; Nemeth, Bertalan ; Kovacs, Sandor ; Zemplenyi, Antal ; Kalo, Zoltan ; Boncz, Imre. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:3:d:10.1007_s40258-021-00710-z.

Full description at Econpapers || Download paper

2022.

Full description at Econpapers || Download paper

2022Cost-Effectiveness of Inotuzumab Ozogamicin Compared to Standard of Care Chemotherapy for Treating Relapsed or Refractory Acute Lymphoblastic Leukaemia Patients in Norway and Sweden. (2022). Ostby, Torup J ; Jakobsson, M ; Russell-Smith, T A ; Oostrum, I ; Heeg, B. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:6:y:2022:i:1:d:10.1007_s41669-021-00287-2.

Full description at Econpapers || Download paper

2022Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy. (2022). Hughes, Dyfrig A ; Garcia-Lorenzo, Borja ; Devlin, Nancy ; Cubi-Molla, Patricia ; Chalkidou, Kalipso ; Cairns, John ; Watson, Sam ; Zamora, Bernarda ; Sampson, Chris ; Towse, Adrian ; Leech, Ashley A. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:5:d:10.1007_s40258-022-00730-3.

Full description at Econpapers || Download paper

2022Towards a Broader Assessment of Value in Vaccines: The BRAVE Way Forward. (2022). Steuten, Lotte ; Neri, Margherita ; Bell, Eleanor. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:20:y:2022:i:1:d:10.1007_s40258-021-00683-z.

Full description at Econpapers || Download paper

2022Value appropriation in hepatitis C. (2022). Jonsson, Bengt ; Weiland, Ola ; Brdvik, Gunnar ; Lofvendahl, Sofia ; Lindgren, Peter. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:23:y:2022:i:6:d:10.1007_s10198-021-01409-7.

Full description at Econpapers || Download paper